Contraception in the COVID-19 pandemic: recommendations from the Korean society of contraception and reproductive health

Coronavirus disease 2019 (COVID-19) is associated with a systemic inflammatory response that activates coagulation in symptomatic patients. In addition, a rare form of thrombosis has been reported in people who received the COVID-19 vaccine, most of whom were women younger than 50 years of age. Considering that hormonal contraceptive methods widely used by women of childbearing age increase the risk of thrombosis, the development of guidelines for the use of hormonal contraceptives in the era of the COVID-19 pandemic is necessary. In this context, the Korean Society of Contraception and Reproductive Health provides guidelines for issues regarding contraception and reproductive health during the pandemic..

Medienart:

E-Artikel

Erscheinungsjahr:

2022

Erschienen:

2022

Enthalten in:

Zur Gesamtaufnahme - volume:65

Enthalten in:

Obstetrics & Gynecology Science - 65(2022), 2, Seite 125-132

Sprache:

Englisch ; Koreanisch

Beteiligte Personen:

Jae Hoon Lee [VerfasserIn]
Jae Yen Song [VerfasserIn]
Kyong Wook Yi [VerfasserIn]
Jin Ju Kim [VerfasserIn]
Kyu Ri Hwang [VerfasserIn]
Jung-Ho Shin [VerfasserIn]
Ji Young Lee [VerfasserIn]
Hee Dong Chae [VerfasserIn]

Links:

doi.org [kostenfrei]
doaj.org [kostenfrei]
www.ogscience.org [kostenfrei]
Journal toc [kostenfrei]
Journal toc [kostenfrei]

Themen:

Combined
Contraception
Contraceptives
Covid-19
Covid-19 vaccines
Gynecology and obstetrics
Long-acting reversible contraception
Oral

doi:

10.5468/ogs.21322

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

DOAJ06568088X